Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

Zealand Pharma - Filing #1440145

Concept 2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
2018-01-01 to
2018-12-31
Disclosure of non-current assets held for sale and discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Profit (loss) before tax
839,653,000 DKK
576,677,000 DKK
625,051,000 DKK
Revenue
353,314,000 DKK
41,333,000 DKK
37,977,000 DKK
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
688,716,000 DKK
409,455,000 DKK
461,420,000 DKK
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
196,807,000 DKK
51,666,000 DKK
882,925,000 DKK
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities
760,941,000 DKK
674,480,000 DKK
155,449,000 DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.